BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, raised $11.5 million in new seed…
BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, raised $11.5 million in new seed…